Gyrolab® AAVX Titer Kit
The Gyrolab® AAVX Titer Kit determines AAV serotypes 1-8 and AAVrh10 titer in samples from process development and in the manufacturing of AAV viral vectors
The AAVX ligand included in Gyrolab® AAVX Titer kit is based on the highly selective affinity ligands developed with the CaptureSelect™ technology from Thermo Fisher Scientific. These ligands are also the basis of POROS™ CaptureSelect™ AAVX Affinity Resin, which is frequently used to purify AAV viral vectors. The generic Gyrolab AAVX Titer Kit in combination with Gyrolab system quickly delivers high quality titer data for AAV serotypes 1–8 and AAVrh10 using smaller sample volumes and with better overall performance compared to ELISA.The kit is not compatible with AAV9. The Gyrolab AAVX Titer Kit includes pre-labeled capture and detect reagents, buffers, consumables, and a Gyrolab Bioaffy™ 1000 disc (96 data points).
Your guide to miniaturized immunoassays for biotherapeutics
Building on advances in microfluidics, next-generation immunoassays offer unparalleled capability in automation and miniaturization, generating robust and reproducible results for faster decision-making.
In this eBook, discover the advantages of automated, miniaturized immunoassays across the drug development pathway, from pre-clinical to bioprocessing. Learn about challenges and trends in immunoassay technology and how automated, miniaturized immunoassays can help you maximize productivity across a range of biopharmaceutical applications, including:
- Research and clinical development
- Insulin quantification
- Anti-drug antibody studies
- In-solution affinity determination
- Vaccine development and production
Gyrolab AAVX Titer Kit: Miniaturized immunoassay results using 10x less sample volume
In this application note, Gyros Protein Technologies highlights the spefications and performance of the Gyrolab AAVX Titer Kit for the quantification of the levels of AAV viral particles in manufacturing processes for cell and gene therapies. The Gyrolab AAVX Titer Kit is designed to deliver high quality AAV titer data for AAV serotypes 1–8 and AAVrh10 from sample volumes of less than 10 µL, and with better overall performance compared to ELISA.
Taking the difficulties out of assay development
Find out how Custom Assay Services from Gyros Protein Technologies accelerate biotherapeutic development
Gene therapy: Reliable capsid titer quantification for AAV-based therapeutics
Guest editorial: Technology to meet the challenge of efficiency in the regulated AAV vector space
Gyros Protein Technologies introduces Gyrolab AAVX Titer Kit to support cell and gene therapy market
Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors
























